In addition to the SRSF2 WT AML samples, we also performed in vivo experiments on SRSF2 WT CD34+ cells from three mobilized peripheral blood samples (Figure 2B); RKI-1447 had no significant inhibiting effect on the engraftment of these cells. Here, CD34 is linked to acute myeloid leukemia.